Citadel Advisors’s Heliogen, Inc. HLGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-214
Closed -$1.84K 15437
2023
Q2
$1.84K Sell
214
-32
-13% -$293 ﹤0.01% 13865
2023
Q1
$2.07K Buy
246
+192
+356% +$2.92K ﹤0.01% 14208
2022
Q4
$1.33K Buy
+54
New +$2.44K ﹤0.01% 14488
2022
Q3
Sell
-791
Closed -$58K 13940
2022
Q2
$58K Sell
791
-1,400
-64% -$182K ﹤0.01% 11845
2022
Q1
$403K Buy
2,191
+517
+31% +$94.4K ﹤0.01% 9882
2021
Q4
$909K Buy
+1,674
New +$587K ﹤0.01% 8195

Other funds holding HLGN

Citadel Advisors's HLGN Position: Q2 2023 in Review

Citadel Advisors sold out of Heliogen, Inc. (HLGN) in Q2 2023, closing a stake of 18 shares — an estimated $165 sold.

Citadel Advisors first reported a position in HLGN in Q4 2021 and held it in 5 quarters. The position peaked at $514K in Q4 2021. 71 funds tracked by Wall St. Rank hold HLGN as of Q2 2023.

  • Citadel Advisors reported no remaining Heliogen, Inc. position as of Q2 2023 after selling out during the quarter.
  • Citadel Advisors sold 18 Heliogen, Inc. shares in Q2 2023, an estimated $165.
  • Citadel Advisors first reported a position in Heliogen, Inc. in Q4 2021 and held it in 5 quarters.
  • Citadel Advisors's Heliogen, Inc. position peaked at $514K in Q4 2021.
  • 71 funds tracked by Wall St. Rank held Heliogen, Inc. as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.